CME Group, the world’s leading derivatives marketplace, along with Morningstar, a leading provider of independent investment insights, announced that they have entered into a multi-year licensing agreement for CME Group to launch derivatives products based on key Morningstar equity index benchmarks, including the Morningstar US Total Market, Large Cap, Large Cap Value, Large Cap Growth, Mid Cap, and Small Cap Indexes.

Through this exclusive agreement, CME Group will offer derivatives on the Morningstar Market Indexes, currently rebranding from CRSP, for the first time, enabling clients to utilize derivatives based on the indexes which underpin over $3 trillion in linked assets.

“We are pleased to partner with Morningstar to help unlock more precise, next-generation risk management tools for the global investment community,” said Tim McCourt, CME Group Senior Managing Director and Global Head of Equities, FX and Alternative Products. “Together, CME Group’s deeply liquid equity derivatives marketplace paired with Morningstar’s data-driven, benchmark ecosystem is expected to allow us to provide our global clients with an optimized framework to safely navigate market volatility and capture new opportunities.”

“We’re excited to collaborate with CME Group to offer derivative products for the first time on the Morningstar Market Indexes, the most definitive and comprehensive measures of the US equity market,” added Morningstar Indexes President Amelia Furr. “With our acquisition of CRSP earlier this year, we have become a leading provider of U.S. equity benchmarks, and the new relationship with CME Group will accelerate our growth even further. Most exciting, we expect to open new doors and bring our high-quality equity indexes to an entirely new segment of the global investment marketplace.”

Source: CME